1 / 48

Secrets of the lac operon: A unified mechanism for aging, diabetes, and obesity

Secrets of the lac operon: A unified mechanism for aging, diabetes, and obesity. Lac operon: Substrates induce their own metabolism, and exhibit hysteresis. The Metabolic Mystery: Aging and Disease. Obesity increases with age Obesity pre-disposes to age-related diseases (metabolic syndrome)

louie
Download Presentation

Secrets of the lac operon: A unified mechanism for aging, diabetes, and obesity

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Secrets of the lac operon:A unified mechanism for aging, diabetes, and obesity

  2. Lac operon: Substrates induce their own metabolism, and exhibit hysteresis

  3. The Metabolic Mystery: Aging and Disease • Obesity increases with age • Obesity pre-disposes to age-related diseases (metabolic syndrome) • Caloric restriction extends lifespan WHY??

  4. WHY?? • Does obesity increase with age? • Does protein oxidation increase with age? • Does glycolysis increase with age? • Does protein turnover decrease with age? • Are effects of aging progressive and apparently irreversible? • Are effects of diabetes progressive and apparently irreversible? • Are effects of aging and diabetes really irreversible?

  5. Caloric (glucose?) restriction Nutrient sensors (transcription factors?) And then a miracle occurs Increased lifespan

  6. How do (glucose) calories kill?Focus on brain gene expression • Diabetic complications mainly in insulin-insensitive tissues • Neurons implicated in many models of aging • Neurons regulate metabolism

  7. Dietary restriction alters characteristics of glucose fuel use.Masoro, EJ, McCarter, RJ, Katz, MS, and McMahan, C AJ. Gerontology (1992) 47(6):B202-B208

  8. Molecular hysteresis: residual effects of hormones and glucose on genes during aging.C.V. MobbsNeurobiology of Aging (1994) 15:523-534

  9. Glucose hysteresis Glucose resistance SIP down VMH neurons glucose resistant Inducedgenes Inhibitedgenes Young&Thin Old& Fat Many meals(glucoseexcursions)

  10. But is it glucose?? • Reducing glucose increases lifespan in yeast • DR (including methionine) reduces glucose • Every-other day feeding does not reduce calories, but reduces glucose and extends lifespan • Elevated glucose causes toxicity (diabetic complications)

  11. What does glucose do?

  12. BUT- Low glucose blocks glycolysis • Phosphofructokinase DOWN • Transaldolase DOWN • Ketohexokinase DOWN • Moncarboxylate transporter 1 Down • Pyruvate dehydrogenase kinase 4 UP

  13. AND- low glucose blocks NADH glycerol shuttle • Mitochondrial glycerolphosphate dehydrogenase DOWN • Cytoplasmic glycerolphosphate dehydrogenase UP

  14. Low glucose stimulates pentose pathway (makes NADPH) • Glucose-6-phosphate dehydrogenase*UP • Linked to aging and stress resistance

  15. Low glucose stimulates TCA cycle and mitochondrial NADPH • Isocitrate dehydrogenase 2*UP • Linked to aging and stress resistance

  16. Low glucose activates hypothalamic mitochondrial lipid oxidation • Carnitine palmitoyl transferase UP • Fatty acid transport protein UP • Mitochondrial Acyl-CoA thioesterase UP

  17. AND- Low glucose activates peroxisomal fatty acid oxidation • Peroxisome membrane protein UP • Peroxysomal Acyl-CoA peroxidase Up • Peroxisomal integral membrane protein UP • Peroxisome membrane protein UP • Peroxisomal integral membrane protein UP • Peroxisomal biogenesis factor UP

  18. AND- Low glucose activates protein and amino acid degradation • Multi-ubiquitin chain binding protein UP • Ubiquitin fusion degradation protein 1 Up • Proteasome delta subunit UP • Proteasome (prosome) subunit UP • Proteasome alpha subunit UP

  19. AND- Low glucose activates protein synthesis • Ribosomal protein S7 UP • Translation initiation factor eIF2 gamma Up • Ribosomal protein S5 UP

  20. Low glucose induces the highly anti-oxidant “glucose switch” profile of gene expression • Glycolysis down (blocks NADH complex I) • Complex I produces free radicals • Pentose pathway up • Makes antioxidant NADPH • Lipid oxidation up (favors FADH2 complex II) • Complex II does not produce free radicals • Amino acid oxidation up • Eliminates oxidatively damaged proteins • Favors NAD+ • Induces protective effects (e.g., SIR1)

  21. The glucose switch: “ATP-neutral” substrate repartitioning Glucose Transport GLUT1 Pentose Shunt Cytoplasm Glycolysis PFK Glucose-6-Phosphate DH NADPH Fatty Acid Oxidation Glucose to Krebs PDHK4 CPT1 PPaRγ NAD+ Krebs Cycle NADH Complex I Complex II FADH2 Isocitrate DH2 NADPH Mitochondria/Peroxisome Respiratory Chain Shift to Complex II

  22. Conversely, high glucose blocks the “glucose switch” profile, leading to an oxidative profile • Glycolysis up (favors NADH complex I) • Complex I produces free radicals • Reduced Complex I, III, IV, and V increase lifespan • Pentose pathway down • Reducing antioxidant NADPH • Lipid oxidation down (inhibits FADH2 complex II) • Complex II does not produce free radicals • Impaired Complex II reduces lifespan • Amino acid oxidation down • Allows accumulation of oxidatively damaged proteins • Favors NAD+ • Inhibits protective mechanisms (e.g., SIR1)

  23. Mechanistic studies: Evidence that NADH mediates toxic effects of glucose a a a a % cells alive (CCK) 100 b 50 b 0 5150 150 15 Glucose Lactate Pyruvate 5 mM Glucose

  24. High-throughput screen discovers drugs protective against glucose toxicity

  25. High-throughput screen discovers drugs protective against glucose toxicity

  26. OK, high glucose can cause oxidative damage acutely, but what accounts for the progressive and (apparently) irreversible nature of age-related impairments?

  27. Hypothalamic glucose sensor: similarities to and differences from pancreatic beta-cell mechanisms.Yang, Kow, Funabashi, MobbsDiabetes 1999 Sep;48(9):1763-72 “The pancreatic, but not hepatic, form of glucokinase was expressed in the VMH..…These data suggest that glucose-responsive neurons sense glucose through glycolysis, specifically the production of NADH, not ATP”.

  28. Implication of glucose switch • Glucose activates its own metabolism (esp. NADH) • Cytoplasmic NADH is the unique signature of glucose, thus particularly suited as a signal • This implies a self-perpetuating, cumulative sensitization or priming effect: HYSTERESIS! • Could this be reversed?

  29. Multistability in the lactose utilization network of Escherichia coliOzbudak et al.Nature (2004) Feb; 427:737-740 “The phase diagram of the wild-type network shows that lac induction always takes place hysteretically, with cells increasing their expression levels discontinuously as a switching threshold is reached….”

  30. Molecular hysteresis in metabolic gene expression

  31. Implication: Aging is reversible

  32. Mechanistic studies: Evidence that NADH mediates toxic effects of glucose a a % cells alive (CCK) 100 b 50 b 0 0100 10 Glucose (mM)

  33. Obesity: What is the question?

  34. How much variability in genetically identical laboratory mice? About the same as in humans! . 20 . . . Body Wt Gain (gm) 15 . . 10 . 5 0 Coefficent of variation: 47%!

  35. Variability in caloric intake is much less than variability in weight gain . . . . . . Caloric intake (kCal) 500 0 Coefficent of variation: 8%!

  36. 20% of retired breeder C57Bl/6J mice don’t gain weight on a high-fat diet but eat each just as much

  37. Diet-induced obesity (independent of food intake) depends on genotype * 25 20 Body weight Gain on HF Diet (grams) 15 10 5 A/JC57

  38. Hypothalamus • According to glucostatic hypothesis A/J mice are resistant to diet-induced obesity because they have increased hypothalamic sensitivity to glucose. This hypothesis implies that induction of genes by hypoglycemia will be less robust in (glucose-sensitive?) A/J mice than in (glucose-insensitive?)

  39. GLUT 1

  40. Ubp41

  41. CITED-1

  42. NPY and AGRP

  43. AGRP (in vitro)

  44. Liver and Cortex Evidence of a hypothalamic defect

  45. Liver: Glut1

  46. Cortex: Glut1

  47. Humanized monoclonal antibody reverses genetic obesity

  48. Anti-obesity effect of FGF antibody is at least partially independent of feeding

More Related